1292804-07-9
1292804-07-9
Chemical Structure
Raltegravir sodium
Synonym(s): MK 0518 sodium
- CAS No.: 1292804-07-9
- Formula:C20H20FN6NaO5
- Molecular Weight:466.40
IUPAC Name: sodium 4-((4-fluorobenzyl)carbamoyl)-1-methyl-2-(2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl)-6-oxo-1,6-dihydropyrimidin-5-olate
InChIKey: QLBNDXLKPYXCIW-UHFFFAOYSA-M
SMILES: O=C(C(N=C(C(NC(C1=NN=C(C)O1)=O)(C)C)N2C)=C(O[Na])C2=O)NCC3=CC=C(F)C=C3
Biological Activity: Raltegravir (MK 0518) sodium is a potent and orally active integrase (IN) inhibitor, used to treat HIV infection.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Raltegravir sodium | Raltegravir (MK 0518) sodium is a potent and orally active integrase (IN) inhibitor, used to treat HIV infection. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
